☆ 3.9 Review

Immune checkpoint alterations and their blockade in COVID-19 patients

BLOOD SCIENCE (2022)

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation

Haibo Wu et al.

Summary: In this study, comprehensive transcriptional and histological analyses were performed on deceased severe COVID-19 patients. The researchers found correlations between the presence of viral antigens and lymphocyte suppression yet myeloid activation, suggesting distinct functions of these cells during pathogenesis. These findings provide valuable insights for understanding the etiology of COVID-19 and developing targeted therapies.

NATURE COMMUNICATIONS (2022)

Add to Collection
Article Multidisciplinary Sciences

Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19

Avraham Unterman et al.

Summary: Using multi-omics single-cell analysis, this study reveals the immune abnormalities associated with progressive COVID-19, including S100A(hi)/HLA-DRlo classical monocytes and activated LAG-3(hi) T cells. It also finds a correlation between T cell receptor repertoire and B cell somatic hypermutation frequency with disease progression.

NATURE COMMUNICATIONS (2022)

Add to Collection
Article Immunology

Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection

Jingzhi Yang et al.

Summary: This study reveals that increased expression of Tim-3 promotes depletion and dysfunction of NKT cells in COVID-19 patients, which is associated with disease severity and outcome. Tim-3+ NKT cells in COVID-19 show higher levels of apoptosis, altered gene expression, and increased secretion of cytokines compared to healthy individuals. Moreover, the up-regulation of Tim-3 in NKT cells is positively correlated with IL-12 secretion by dendritic cells in COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection
Article Respiratory System

Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection

Claudia Ravaglia et al.

Summary: This study analyzes the morphological and immunomolecular features of lung tissue in patients with post-COVID-19 lung disease. Different phenotypes with potentially different underlying pathogenic mechanisms have been identified, providing a better understanding of lung abnormalities after SARS-CoV-2 infection.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection
Article Immunology

Unique immunological profile in patients with COVID-19

Stefania Varchetta et al.

Summary: The study found abnormal immune responses in COVID-19 patients, including exhaustion of NK cells and CD8(+)T cells, elevated levels of IL-6, and excessive secretion of inflammatory cytokines by monocytes. Patients with poor outcomes exhibited more severe immune dysregulation.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection
Article Immunology

TIM-3 as a potential exhaustion marker in CD4+ T cells of COVID-19 patients

Zahra Modabber et al.

Summary: The study found that TIM-3 expression on CD4(+) T cells is significantly increased in COVID-19 patients, serving as an important marker of exhaustion. Patients exhibited lymphopenia, elevated inflammatory and biochemical parameters compared to healthy individuals.

IMMUNITY INFLAMMATION AND DISEASE (2021)

Add to Collection
Article Allergy

Compartmental immunophenotyping in COVID-19 ARDS: A case series

Andreas Ronit et al.

Summary: In critically ill patients with COVID-19 ARDS, there is a distinct immunological profile in the lungs, characterized by a dominance of immature neutrophils, lymphopenia of CD4 and CD8 T cells, and higher fractions of regulatory T cells and TH17 cells. The lung exhibits a heavily hyperinflammatory environment with upregulation of activation markers on CD4 and CD8 T cells and macrophages, along with high levels of various cytokines such as IL-1RA, IL-6, IL-8, IP-10, and MCP-1.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection
Article Allergy

Elevated plasma sTIM-3 levels in patients with severe COVID-19

Thor Ueland et al.

Summary: The study found that severe clinical outcomes in COVID-19-infected patients, such as requiring ICU treatment, were associated with high plasma levels of sTIM-3 and myeloperoxidase, indicating activated and potentially exhausted T cells and activated neutrophils. However, levels of sCD14 and sCD163 showed no association with ICU treatment. Additionally, levels of sCD25, sTIM-3, and myeloperoxidase were inversely correlated with the degree of respiratory failure but positively correlated with the cardiac marker N-terminal pro-B-type natriuretic peptide.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection
Article Immunology

PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19

Min-Seok Rha et al.

Summary: Memory T cell responses have been observed in COVID-19 convalescents, with specific T cells showing different phenotypes during the recovery phase. SARS-CoV-2-specific CD8(+) T cells displayed early differentiated effector-memory phenotypes in the early convalescent phase and an increased proportion of stem-like memory cells in the late convalescent phase. Compared to influenza A virus-specific CD8(+) T cells, SARS-CoV-2-specific CD8(+) T cells had a lower frequency of IFN-gamma-producing cells. Additionally, PD-1-expressing SARS-CoV-2-specific CD8(+) T cells were functional rather than exhausted.

IMMUNITY (2021)

Add to Collection
Review Oncology

Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)

Silvia Vivarelli et al.

Summary: The treatment of COVID-19 is still lacking a clear and effective drug, but there is hope to use immune checkpoint inhibitors to restore the function of T cells in patients to combat viral infections.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Add to Collection
Article Medicine, Research & Experimental

Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection

Jacob K. Files et al.

Summary: SARS-CoV-2 infection leads to a prolonged period of immune dysregulation, with increased activation and exhaustion markers in T cells and B cells in both hospitalized and nonhospitalized individuals. The changes in T cell activation/exhaustion positively correlate with age, and severely infected individuals exhibited higher expression of activation and exhaustion markers.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection
Article Cell Biology

B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19

Nils H. Wildner et al.

Summary: This study utilized 16-color flow cytometry analysis to investigate peripheral B cells in patients with SARS-CoV-2 infection or acute Plasmodium falciparum malaria. The results showed an increase in atypical memory B cells and plasmablasts in these patients, along with changes in specific protein expression on the plasmablasts. These changes were positively correlated with inflammatory markers in COVID-19 patients.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Add to Collection
Article Immunology

Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells

Anthony Kusnadi et al.

Summary: CD8(+) T cells in COVID-19 patients exhibit two distinct states – exhausted and non-exhausted, with non-exhausted cells in severe cases showing enhanced memory responses to SARS-CoV-2 infection.

SCIENCE IMMUNOLOGY (2021)

Add to Collection
Article Biology

Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression

Andre F. Rendeiro et al.

Summary: A study on COVID-19 patients found dynamic changes in innate and adaptive immune cells during disease progression, with significant absolute changes in lymphocyte and myeloid cells in severe cases. Intubation and death were associated with selected natural killer cell KIR receptor usage and IgM+ B cells, along with profound CD4 and CD8 T-cell exhaustion.

LIFE SCIENCE ALLIANCE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19

Can Liu et al.

Summary: This study longitudinally assessed various factors in single peripheral immune cells of COVID-19 patients and identified primary correlates of disease severity and outcome. Timing was emphasized as crucial in the analysis, clinical monitoring, and therapeutic intervention of COVID-19.

CELL (2021)

Add to Collection
Review Cell Biology

Galectin-9 as a biomarker of disease severity

Preeti Moar et al.

Summary: Galectin-9 is a widely expressed protein involved in cell signaling and host-pathogen interactions. Recent studies have found elevated levels of Galectin-9 in various diseases, including cancer and autoimmune disorders.

CELLULAR IMMUNOLOGY (2021)

Add to Collection
Letter Oncology

SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry

Rose K. C. Moritz et al.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression

Ata Mahmoodpoor et al.

Summary: Patients with COVID-19 exhibited reduced number and function of T cells, with more significant changes in severe cases. Levels of proinflammatory cytokines were increased and correlated with disease severity. High levels of serum IL-2R were considered a sign of lymphopenia, while hypercholesterolemia and hyperlipidemia could serve as important prognostic factors.

MOLECULAR IMMUNOLOGY (2021)

Add to Collection
Article Immunology

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

Agnes Bonifacius et al.

Summary: Research showed that active COVID-19 patients had high levels of anti-SARS-CoV-2 nucleocapsid and spike IgG, but overall reduced antiviral T cell responses due to inflammatory environment, expression of inhibitory molecules, and effector caspase activity in T cells.

IMMUNITY (2021)

Add to Collection
Article Immunology

The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression

Wei Huang et al.

Summary: COVID-19 is associated with immune dysregulation and cytokine storm, leading to altered levels of various immune cells and cytokines in the body. Some specific factors could potentially be used as biomarkers for predicting disease severity and progression.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection
Review Oncology

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Deborah Blythe Doroshow et al.

Summary: PD-L1 expression is currently the best predictor of responsiveness to immune-checkpoint inhibitors, despite challenges in clinical use such as variability in different assays and cut-off points, as well as the lack of prospective comparisons with clinical outcomes. Nevertheless, several immunohistochemical assays have been approved for clinical use, with implications for pathology services and potential impacts on clinical outcomes. Comparison of FDA-approved PD-L1 assays, understanding of the varying implications of PD-L1 expression across different tumour types, and exploration of novel approaches to optimize its clinical utility are important topics for further research and practice.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection
Article Cell Biology

Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19

Jingyi Yang et al.

Summary: The study revealed significant alterations in the immune status of lymphocytes in COVID-19-recovered patients, suggesting potential dysfunction even after clinical recovery. No tendency toward recovery within 4-11 weeks post discharge was observed for phenotypes associated with reduced function.

JOURNAL OF MOLECULAR CELL BIOLOGY (2021)

Add to Collection
Article Immunology

VISTA: A Target to Manage the Innate Cytokine Storm

Mohamed A. ElTanbouly et al.

Summary: In recent years, immunotherapy targeting immune checkpoints has shown success in cancer treatment, leading to interest in targeting these receptors in other immune related diseases. V-domain Ig suppressor of T cell activation (VISTA) has emerged as a potential therapeutic target with unique anti-inflammatory effects on myeloid cells. The agonistic targeting of VISTA can profoundly change the phenotype of human monocytes and suppress pathologies mediated by the innate immune system.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Medicine, Research & Experimental

Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection

Narjes Saheb Sharif-Askari et al.

Summary: The research found that immune inhibitory receptors were overall upregulated at the mRNA level during COVID-19 infection, especially lymphoid-associated inhibitory receptors in severe cases. Some shared genes were more expressed in autopsies and correlated with viral levels. Single-cell data also reflected the association between upregulation of inhibitory receptors and disease severity.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Add to Collection
Letter Immunology

Enrichment of CCR6+CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19

Anno Saris et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Add to Collection
Article Immunology

Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests

Yue Zhou et al.

Summary: During the COVID-19 pandemic, some critically ill patients were unable to be discharged from the ICU despite negative viral tests, leading to a study on the gene expression profiles of peripheral immune cells. The findings showed severely decreased expression of adaptive immunity-related genes in these patients, particularly related to T/B cells and HLA molecules, resulting in long-term secondary infections. No significant change was observed in classic immunosuppression molecules, suggesting that this adaptive immune suppression may be caused by dysregulated host response to severe infection.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia

Gaowa Bai et al.

Summary: The levels of FL-Gal9, FL-OPN, Tr-Gal9, and Ud-OPN were significantly elevated in COVID-19 patients, with Tr-Gal9 and Ud-OPN showing significant associations with laboratory markers for lung function, inflammation, coagulopathy, and kidney function. Treatment with tocilizumab in CP patients led to reduced levels of FL-Gal9, Tr-Gal9, and Ud-OPN.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection
Article Infectious Diseases

Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19

Sumeyye Kazancioglu et al.

Summary: This study investigated Galectin-1 (Gal-1), Galectin-3 (Gal-3), and prostaglandin E2 (PGE2) levels in patients with COVID-19, finding that levels were higher in COVID-19 patients compared to healthy controls. Gal-3 was identified as a potential prognostic biomarker for disease severity.

JAPANESE JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection
Article Cell Biology

NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19

Laura Bergantini et al.

Summary: The study found that COVID-19 patients had fewer CD56(dim)CD16(bright)NKG2A(+)NK cells and an increase in CD56(+)CD69(+)NK, CD56(+)PD-1(+)NK, CD56(+)NKp44(+)NK subsets compared to healthy controls. Patients with severe disease showed higher adaptive/memory-like NK cell frequency, and those who died had significantly higher adaptive/memory-like NK cell frequencies. Severe COVID-19 patients exhibited higher serum concentrations of IL-6 than mild and control groups.

CELLS (2021)

Add to Collection
Review Oncology

TIM-3 in Leukemia; Immune Response and Beyond

Mahnaz Rezaei et al.

Summary: TIM-3 expression in leukemia cells plays a role in immune escape. TIM-3 inhibitors show promising responses in MDS and AML treatment. Blocking TIM-3 may have dual effects by inhibiting leukemia cell proliferation and restoring T cell function, but its effects may differ in different types of leukemia, requiring further research.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection
Article Immunology

Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients

Mehdi Shahbazi et al.

Summary: The study found that the percentage of CD8+ cells in COVID-19 patients was significantly lower, and patients were more likely to have an increased frequency of CD8+ TIM-3+, CD8+ CD39+, and CD8+ TIM-3+ CD39+ cells. There were no significant differences between groups in terms of CD8+ PD-1+ cell counts.

MICROBIAL PATHOGENESIS (2021)

Add to Collection
Review Pathology

The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime

Marco Chilosi et al.

Summary: The understanding of the complex pathogenesis of COVID-19 interstitial pneumonia has been discussed in this article based on biopsies carried out in early/moderate phases and histology data obtained at postmortem analysis. The observations from autopsies cannot fully explain some clinical, radiological and physiopathological features observed in SARS-CoV-2 interstitial pneumonia, suggesting the need for further research to understand the discrepancies.

MODERN PATHOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Single-cell multi-omics analysis of the immune response in COVID-19

Emily Stephenson et al.

Summary: Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated with disease severity.

NATURE MEDICINE (2021)

Add to Collection
Article Oncology

Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors

Nikolai Klebanov et al.

Summary: The study aimed to determine the rate of COVID-19 among cancer patients treated with immune checkpoint inhibitors (ICIs). Results showed that there was no significant increase in COVID-19 susceptibility in the ICI group compared to controls. This information may help patients and oncologists make decisions about cancer treatment during the pandemic.

ONCOLOGIST (2021)

Add to Collection
Article Microbiology

Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment

Jia Liu et al.

mBio (2021)

Add to Collection
Article Microbiology

Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection

Najmeh Bozorgmehr et al.

Summary: The outbreak of SARS-CoV-2 infection has significantly impacted our lives, with cytokine release syndrome being identified as a major cause of mortality in COVID-19 patients. Studies have shown a substantial increase in plasma Galectin-9 (Gal-9) levels in COVID-19 patients compared to healthy controls. Gal-9 may play a critical role in the pathogenesis of COVID-19, and inhibiting Gal-9 could be a potential therapeutic strategy to modulate hyperimmune activation in these patients.

MBIO (2021)

Add to Collection
Review Microbiology

Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival

Takayuki Murata

Summary: The immune system's activation and regulated downregulation are crucial for preventing immune disorders. The PD-1/PD-L1 pathway benefits the host but can also be exploited by pathogens to evade immunity. Herpesviruses like HSV, CMV, and EBV have complex relationships with this pathway and understanding them is essential for developing effective preventative and therapeutic methods.

MICROORGANISMS (2021)

Add to Collection
Article Allergy

Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection

Hongyan Hou et al.

Summary: This study found that convalescent patients with COVID-19 maintained robust SARS-CoV-2-specific humoral and cellular responses at 1 year postinfection. However, dysfunction in specific CD4+ T cells suggests that vaccination is necessary in these patients to prevent reinfection.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection
Article Immunology

Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19

Aaron J. Wilk et al.

Summary: The study revealed immune system dysfunctions in COVID-19 patients at different disease severity stages, particularly in severe and fatal cases. It also found a lack of pro-inflammatory cytokine production in severe cases, potentially due to chromatin accessibility changes as a mechanism.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection
Article Immunology

The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated

Shima Shahbaz et al.

Summary: Understanding the function of SARS-CoV-2 Ag-specific T cells is crucial for antiviral immunity monitoring and vaccine design. This study reveals that while there are variations in T cell responses to viral peptide pools among COVID-19 patients, the expression of coinhibitory receptors is associated with increased frequencies of cytokine-producing T cells. A Th2 phenotype may be linked to milder disease, while a robust Th17 response is associated with severe disease.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection
Article Microbiology

Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection

Martina Severa et al.

Summary: The study highlights the crucial role of pDC/type I IFN axis in defending against SARS-CoV-2 infection in COVID-19 patients, suggesting that a deeper understanding may aid in the development of new drug strategies and host-directed therapies. Moreover, the findings indicate that critically ill patients exhibit impaired type I IFN response and high levels of inflammatory cytokines and chemokines, leading to multi-organ failure.

PLOS PATHOGENS (2021)

Add to Collection
Article Immunology

Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype

Amelia C. Trombetta et al.

Summary: This study found that the acquisition of an immune-regulatory myeloid cell phenotype may contribute to recovery in severe COVID-19 patients, and therapeutic agents favoring an innate immune system regulatory shift could be the best strategy at this stage.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Immunology

Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19

Po-Ku Chen et al.

Summary: This study found that AOSD patients and severe COVID-19 patients have significantly higher levels of galectins and cytokines compared to healthy controls. Active AOSD patients showed elevated IFN-gamma and IL-17A compared to healthy controls. IL-18 is a key discriminator between active AOSD and severe COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Review Oncology

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers

Vito Amodio et al.

Summary: A subset of colorectal cancers with mismatch repair deficiency are sensitive to immune checkpoint inhibitors, but some patients show primary resistance or develop acquired resistance. Changes in the Wnt and JAK-STAT signaling pathways, as well as alterations in the antigen presentation machinery, are associated with resistance to CPIs in these patients. Understanding the mechanistic basis of immune evasion in CRC provides rationale for innovative strategies to increase the subset of patients benefiting from CPIs.

CANCERS (2021)

Add to Collection
Review Oncology

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer

Clemence Demerle et al.

Summary: Lung cancer is a leading cause of cancer deaths worldwide, and immunotherapies have shown promising results in treatment. However, only 25% of cases show durable responses, highlighting the need for new immunotherapy targets. Among these targets, the BTLA-HVEM couple appears to be a promising candidate for designing new immunotherapies.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study

Gerardo Cazzato et al.

Summary: This study examines skin immunopathology in SARS-CoV-2 positive individuals. Results suggest immune deregulation in those who develop various skin manifestations, with increased activation of HMGB-1 and TIM-3 and decreased expression of Heme oxygenase 1 in the skin samples.

BIOMOLECULES (2021)

Add to Collection
Review Oncology

Extracellular and nuclear PD-L1 in modulating cancer immunotherapy

Wenjun Xiong et al.

Summary: Understanding the regulatory mechanisms of the PD-1/PD-L1 axis is crucial for overcoming obstacles of PD-1/PD-L1 blockade. The roles of extracellular and nuclear PD-L1 play a critical role in regulating cancer immune evasion and immunotherapy.

TRENDS IN CANCER (2021)

Add to Collection
Article Biochemistry & Molecular Biology

A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis

Katie-May McLaughlin et al.

Summary: In the ongoing COVID-19 pandemic caused by the coronavirus SARS-CoV-2, elevated levels of CD47 may contribute to disease severity and are associated with risk factors such as older age and diabetes. Research suggests that high CD47 levels may predispose individuals infected with SARS-CoV-2 to develop severe complications.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)

Add to Collection
Article Medicine, Research & Experimental

NK cell receptor and ligand composition influences the clearance of SARS-CoV-2

Wan-Chen Hsieh et al.

Summary: By profiling the immune systems of 21 patients recovered from SARS-CoV-2 infection, it was found that the diversity of receptors on NK cells was negatively correlated with viral clearance rate, with NK subsets expressing DNAM1 increased in rapidly recovering patients. Functional studies showed that NK subpopulations with high DNAM1 expression exhibited cytolytic activities in response to target cell stimulation. The study also revealed that SARS-CoV-2 infection induced the expression of CD155 and nectin-4, ligands of DNAM1 and its paired coinhibitory receptor TIGIT, which counteracted the cytolytic activities of NK cells, modulating host-pathogen interactions during SARS-CoV-2 infection.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection
Review Oncology

Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature

Laura Pala et al.

Summary: The impact of COVID-19 pandemic on cancer patients requires further research, but limited data supports the possibility of continuing immunotherapy in patients with cancer under control.

CANCER INVESTIGATION (2021)

Add to Collection
Article Oncology

Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+T cells in patients with acute myeloid leukemia

Jiaxiong Tan et al.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection
Editorial Material Immunology

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Meijuan Zheng et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection
Letter Immunology

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

Hong-Yi Zheng et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection
Editorial Material Immunology

NKG2A and COVID-19: another brick in the wall

Luca Antonioli et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection
Article Immunology

Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells

Yueping Liu et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection
Article Immunology

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Bo Diao et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Review Pharmacology & Pharmacy

Mechanisms of HBV immune evasion

Adrian Kuipery et al.

ANTIVIRAL RESEARCH (2020)

Add to Collection
Article Hematology

Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients

Silvia Bellesi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection
Article Immunology

Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease

Christoph Schultheiss et al.

IMMUNITY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

Add to Collection
Article Biochemistry & Molecular Biology

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Aaron J. Wilk et al.

NATURE MEDICINE (2020)

Add to Collection
Article Pharmacology & Pharmacy

Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)

Si-Yang Liu et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Add to Collection
Article Multidisciplinary Sciences

Immunological and inflammatory profiles in mild and severe cases of COVID-19

Jin-Wen Song et al.

NATURE COMMUNICATIONS (2020)

Add to Collection
Article Multidisciplinary Sciences

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

Sara De Biasi et al.

NATURE COMMUNICATIONS (2020)

Add to Collection
Article Immunology

A Granulocytic Signature Identifies COVID-19 and Its Severity

Joana Vitte et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection
Article Microbiology

Impaired Cytotoxic CD8(+) T Cell Response in Elderly COVID-19 Patients

Jaana Westmeier et al.

MBIO (2020)

Add to Collection
Article Immunology

Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to AcutePlasmodium falciparumMalaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease

Marissa Herrmann et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Article Cell Biology

Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness

Zuzana Parackova et al.

CELLS (2020)

Add to Collection
Article Immunology

Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset

Juan Francisco Gutierrez-Bautista et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Article Cell Biology

Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19

Lin Yan et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Add to Collection
Review Hematology

T cell response in patients with COVID-19

Lian Liu et al.

BLOOD SCIENCE (2020)

Add to Collection
Letter Biochemistry & Molecular Biology

Storm of soluble immune checkpoints associated with disease severity of COVID-19

Yaxian Kong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection
Article Oncology

Increased PD-1+Tim-3+exhausted T cells in bone marrow may influence the clinical outcome of patients with AML

Jiaxiong Tan et al.

BIOMARKER RESEARCH (2020)

Add to Collection
Review Oncology

Is CD47 an innate immune checkpoint for tumor evasion?

Xiaojuan Liu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)

Add to Collection
Article Multidisciplinary Sciences

Unifying mechanism for different fibrotic diseases

Gerlinde Wernig et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Add to Collection
Article Oncology

Higher PD-1 expression concurrent with exhausted CD8+T cells in patients with de novo acute myeloid leukemia

Jiaxiong Tan et al.

CHINESE JOURNAL OF CANCER RESEARCH (2017)

Add to Collection
Article Immunology

Molecular signature of CD8+ T cell exhaustion during chronic viral infection

E. John Wherry et al.

IMMUNITY (2007)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.